These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Perspectives on clinical trials in the rheumatic diseases. Hart FD Clin Rheum Dis; 1983 Dec; 9(3):491-8. PubMed ID: 6606529 [No Abstract] [Full Text] [Related]
4. [Methodological deficiencies in clinical trials]. Nahler G Fortschr Med; 1992 Oct; 110(28):511-4. PubMed ID: 1398408 [TBL] [Abstract][Full Text] [Related]
5. Methods of randomization in controlled clinical trials. Moeschberger ML; Williams JA; Brown CG Am J Emerg Med; 1985 Sep; 3(5):467-73. PubMed ID: 4041198 [TBL] [Abstract][Full Text] [Related]
6. The principles of controlled clinical trials of drugs. Herman ZS Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):361-4. PubMed ID: 357309 [TBL] [Abstract][Full Text] [Related]
7. An efficient design for phase III studies of combination chemotherapies. Ellenberg SS; Eisenberger MA Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093 [No Abstract] [Full Text] [Related]
8. Design and analysis of prostate cancer trials. Sylvester R Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926 [TBL] [Abstract][Full Text] [Related]
9. A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. Bombardier C; Tugwell P J Rheumatol; 1982; 9(5):753-7. PubMed ID: 6983581 [No Abstract] [Full Text] [Related]
10. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials. Gail MH Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091 [TBL] [Abstract][Full Text] [Related]
11. Are better endpoints and better design of clinical trials needed? Fransen J; van Riel PL Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):97-109. PubMed ID: 15123040 [TBL] [Abstract][Full Text] [Related]
12. [Statistical methods in the evaluation of the therapeutic efficacy--their problems and solutions]. Tominaga S Gan To Kagaku Ryoho; 1982 Nov; 9(11):1873-81. PubMed ID: 6764094 [TBL] [Abstract][Full Text] [Related]
13. Need for large sample sizes in randomized trials. Hennekens C; Buring JE Pediatrics; 1987 Apr; 79(4):569-71. PubMed ID: 3822676 [No Abstract] [Full Text] [Related]
14. Clinical trials in rheumatic diseases: designs and limitations. Pincus T; Sokka T Rheum Dis Clin North Am; 2004 Nov; 30(4):701-24, v-vi. PubMed ID: 15488689 [TBL] [Abstract][Full Text] [Related]
15. Limitations to standard randomized controlled clinical trials to evaluate combination therapies in rheumatic diseases. Pincus T Agents Actions Suppl; 1993; 44():83-91. PubMed ID: 8372739 [TBL] [Abstract][Full Text] [Related]
16. [Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials]. Byar D; Chastang C Bull Cancer; 1987; 74(2):177-84. PubMed ID: 3607300 [TBL] [Abstract][Full Text] [Related]
17. [Design and analysis of a treatment study in urological clinical research]. Vargas Castrillón E; Terleira Fernández A Arch Esp Urol; 2003; 56(6):615-28. PubMed ID: 12958996 [TBL] [Abstract][Full Text] [Related]
18. Dropouts and missing data in psychiatric clinical trials. Potkin SG; Siu CO Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237 [No Abstract] [Full Text] [Related]
19. Prognostic factors for randomization and stratification and endpoints for the evaluation of trials. Sylvester RJ; Suciu S; Yamanaka H Prog Clin Biol Res; 1988; 269():275-87. PubMed ID: 3293065 [No Abstract] [Full Text] [Related]
20. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Geller NL; Pocock SJ Biometrics; 1987 Mar; 43(1):213-23. PubMed ID: 3567306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]